Modulatory effect of bradykinin on the release of noradrenaline from rat isolated atria

British Journal of Pharmacology

Volumn 115, Issue 2, 1995, Pages 330-334

  Chulak, Chantal ^a   Couture, Réjean ^a   Foucart, Sylvain ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

bradykinin; kinin receptors; Noradrenaline release; protein kinase C; rat atria

Indexed keywords

ANGIOTENSIN; BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ[8 LEUCINE 9 DEARGININE]; DICLOFENAC; ICATIBANT; MALEIMIDE DERIVATIVE; NORADRENALIN; PHORBOL DIBUTYRATE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN KINASE C;

ANIMAL TISSUE; ARTICLE; HEART ATRIUM; HEART STIMULATION; ISOLATED HEART; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SECOND MESSENGER;

ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMAL; BRADYKININ; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTRIC STIMULATION; FENOTEROL; HEART ATRIUM; INDOLES; MALE; MALEIMIDES; NOREPINEPHRINE; PHORBOL 12,13-DIBUTYRATE; PROTEIN KINASE C; RATS; RATS, WISTAR; SUPPORT, NON-U.S. GOV'T;

EID: 0029033731     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1995.tb15881.x     Document Type: Article

References (27)

1. Polymyxin B, a selective inhibitor of protein kinase C, diminishes the release of noradrenaline and the enhancement of release caused by phorbol 12,13‐dibutyrate.
2. Effect of phorbol esters on noradrenaline release from cerebral arteries.
3. Characterization of bradykinin mediating pertussis toxin‐insensitive biphasic response in circular muscle of isolated guinea‐pig ileum.
4. Effect of protein kinase C and calcium on bradykinin‐mediated contractions of rabbit vessels.
5. 9‐bradykinin.
6. Changes in peripheral sympathetic outflow of pithed spontaneously hypertensive rats after bradykinin and des‐Arg‐bradykinin infusions: influence of converting‐enzyme inhibition.
7. Long term treatment with phorbol esters suggests a permissive role for protein kinase C in the enhancement of noradrenaline release.
8. Bradykinin receptors: pharmacological properties and biological roles.
9. Cloning and pharmacological characterization of bradykinin receptors.
10. Cloning and pharmacological characterization of human bradykinin (BK‐2) receptor.
11. Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studies.
12. 3H]‐noradrenaline.
13. Involvement of cyclic nucleotides in prejunctional modulation of noradrenaline release in mouse atria.
14. New, long‐acting, potent bradykinin antagonists.
15. Bradykinin modulates the release of noradrenaline from vas deferens nerve terminals.
16. Second messengers are involved in facilitatory but not inhibitory receptor actions at sympathetic nerve endings
17. Pharmacology of kinins: their relevance to tissue injury and inflammation.
18. Expression cloning of a human B. bradykinin receptor.
19. Importance of sympathetic innervation in the positive inotropic effects of bradykinin and ramiprilat.
20. Evidence that angiotensin II enhances noradrenaline release from sympathetic nerves in mouse atria by activating protein kinase C.
21. 2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs.
22. Regulation of noradrenaline release by presynaptic receptor systems.
23. Bradykinin and postganglionic sympathetic transmission.
24. ++ dependent protein kinase.
25. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.
26. 3H]‐norepinephrine release in rat hypothalamus.
27. Phorbol ester, an activator of protein kinase C, enhances calcium‐dependent release of sympathetic neurotransmitter.